- Home
- GOTU vs KROS Comparison
GOTU vs KROS Comparison
Compare GOTU & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOTU
- KROS
- Stock Information
- Founded
- GOTU 2014
- KROS 2015
- Country
- GOTU China
- KROS United States
- Employees
- GOTU N/A
- KROS N/A
- Industry
- GOTU Other Consumer Services
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- GOTU Real Estate
- KROS Health Care
- Exchange
- GOTU Nasdaq
- KROS Nasdaq
- Market Cap
- GOTU 864.7M
- KROS 565.0M
- IPO Year
- GOTU 2019
- KROS 2020
- Fundamental
- Price
- GOTU $3.61
- KROS $15.80
- Analyst Decision
- GOTU
- KROS Buy
- Analyst Count
- GOTU 0
- KROS 14
- Target Price
- GOTU N/A
- KROS $20.56
- AVG Volume (30 Days)
- GOTU 895.7K
- KROS 417.9K
- Earning Date
- GOTU 08-26-2025
- KROS 11-05-2025
- Dividend Yield
- GOTU N/A
- KROS N/A
- EPS Growth
- GOTU N/A
- KROS N/A
- EPS
- GOTU N/A
- KROS 0.47
- Revenue
- GOTU $764,860,130.00
- KROS $232,844,000.00
- Revenue This Year
- GOTU $36.33
- KROS $5,579.44
- Revenue Next Year
- GOTU $24.36
- KROS N/A
- P/E Ratio
- GOTU N/A
- KROS $34.08
- Revenue Growth
- GOTU 56.23
- KROS 85820.30
- 52 Week Low
- GOTU $1.87
- KROS $9.12
- 52 Week High
- GOTU $4.59
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- GOTU 45.84
- KROS 60.69
- Support Level
- GOTU $3.53
- KROS $15.34
- Resistance Level
- GOTU $3.72
- KROS $15.85
- Average True Range (ATR)
- GOTU 0.16
- KROS 0.48
- MACD
- GOTU -0.02
- KROS -0.01
- Stochastic Oscillator
- GOTU 16.94
- KROS 78.71
About GOTU Gaotu Techedu Inc.
Gaotu Techedu Inc is a technology-driven education company that provides online live courses in a large-class setting backed by its proprietary technology infrastructure. The company offers courses in large-class format, which amplifies the benefits of online education and allows it to rapidly expand its student base. It operates solely in the PRC and all assets are located in the PRC. The learning services that the company offers include Traditional Learning Services, Non-Academic Tutoring Services, and College Student and Adult Education Services. It derives maximum revenue from Learning Services and also from Educational content & digitalized learning products.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.